INS and Hypoglycemia: Compared to MDIs or traditional continuous subcutaneous infusion of insulin, sensor-augmented pump (SAP) therapy, which integrates insulin pump therapy and real-time continuous glycaemic monitoring, has enhanced metabolic control and has lowered the incidence of hypoglycemia in patients having type I diabetes mellitus [15].